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ABSTRACT
Introduction: As part of a control strategy
current guidance in the UK recommends more
intense surveillance of HbA1C levels among
those of South-east Asian or Chinese ethnicity
above specified BMI thresholds. The objective of
this study was to determine whether disparities
in the identification and control of diabetes in
England persisted despite these guidelines and
assess current strategies in light of these
findings.
Methods: Data were extracted from the 2013
Health Survey for England that included eth-
nicity, BMI status and HbA1C levels. Descriptive
statistics and logistic regression analyses were
used to examine relationships among unde-
tected diabetes, poorly controlled diabetes and a
range of covariates including ethnicity and BMI.
Concentration indices were used to examine
the socio-economic gradient in disease
detection and control among and between
ethnic groups.
Results: In regression models that controlled
for a range of covariates Asians were found to
have a 5% point higher risk of undetected dia-
betes than Whites. With respect to disease
management, Bangladeshis and Pakistanis were
found to be at a 28% point and 21% point
higher risk of poor disease control respectively
than Whites. Concentration indices revealed
better disease control among more affluent
Whites than poor Whites, no significant pattern
between income and disease management was
found among Pakistanis and poorer disease
control was more evident among more affluent
than poorer Bangladeshis.
Conclusion: In the UK current guidance rec-
ommends practitioners consider testing for
diabetes among South-east Asians and Chinese
where BMI exceeds 23. Our findings suggest
that the risk experienced by Asians in disease
detection is independent of BMI and may war-
rant a more active screening policy than cur-
rently recommended. With respect to disease
management, our findings suggest that Indians
and Pakistanis experience particularly high
levels of poor disease control that may also be
usefully reflected in guidance.
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INTRODUCTION
Diabetes is characterised by an impaired ability
to produce or respond to the hormone insulin.
Between 90% and 95% of diabetics suffer from
type 2 diabetes [29]. The disease is associated
with a significant economic burden
[1, 11, 12, 31, 38] that based on current trends
seems set to increase in many countries
[7, 39, 41]. That it can remain asymptomatic for
several years contributes to this burden by
allowing complications associated with it to
accumulate that could be avoided were it
detected and managed earlier [8, 10, 34]. While
prompt identification and effective manage-
ment are clearly important to avoiding such
costs, several studies highlight not only the
existence of a substantial prevalence of undi-
agnosed disease [4, 14, 17, 20, 28, 32] but also
the existence of distinct patterns of undiag-
nosed disease. In the UK, Moody et al. [20], for
example, found that males, those who are older
(greater than 34 years) and those who are ethnic
Asians were more likely to have undiagnosed
diabetes. In the US, Menke et al (2015) [17]
similarly found that rates of undiagnosed dia-
betes were higher among those who were older
(45 years plus) and among Asians compared
with Whites or younger persons.
Other studies point to similar patterns
regarding glycaemic control among those with
diagnosed diabetes. In Scotland, for example,
Negandhi et al. [21] highlight higher levels of
HbA1C (a measure of glycated haemoglobin
used to define diabetes status) among those of
Pakistani and Indian ethnicity compared to
White Scottish, findings echoed elsewhere in
the UK by James et al. [13]. Similar findings were
evident in Sweden, where native Swedes
exhibited better glycaemic control relative to
those of South-east Asian ethnicity [26] and in
the US where Non-hispanic Blacks [5, 9] and
Mexican-American men [9] exhibited poorer
glycaemic control relative to Whites.
Beyond ethnicity, studies provide mixed
evidence regarding the role of socio-economic
status (SES) in undiagnosed and poorly con-
trolled diabetes. Some such as Lee et al (2015)
[15] report a higher prevalence of undiagnosed
diabetes among the less well off compared to
the better off in Korea, as do Moody et al. [20] in
the UK and Zhang et al. [40] in China. By con-
trast, others such as [33, 41] found no role for
income in the US with similar findings by
Rathmann et al. [25] in Germany. Similarly,
concerning education, the evidence is mixed.
Zhang et al. [41], Lee et al. [15] and Wilder et al.
[33] found no role for education in undiagnosed
diabetes while Moody et al. [20] found that
those who were better educated were less likely
to be undiagnosed. A similar pattern is found
regarding glycaemic control among those diag-
nosed with diabetes. While Zhang et al. [40] and
Moody et al. [20] found those who were better
educated exhibited better glycaemic control
than those who were not, Lee et al. [15] found
no role for education in glycaemic control and
Marden et al. [16] found numeracy but not lit-
eracy skills were important in glycaemic
control.
Relationships reported in the literature can
be seen to have informed screening guidelines
for diabetes. In the UK, for example, the
National Institute for Health and Clinical
Excellence recommend that general practition-
ers should consider blood tests for those aged 25
and over of South Asian or Chinese descent
whose body mass index (BMI) is greater than
23 kg/m2 [22]. While a little different in terms of
specifics, similar risk profiling related to age,
obesity and ethnicity features in guidance
offered by the US Preventive Services Task Force
[30] though others have mooted the use of dif-
ferent thresholds for assessing diabetes risk
related to ethnicity given different relationships
between HbA1C and other measures of blood
glucose across ethnic groups [2, 36].
The objective of this study is to ascertain
whether current guidance related to diabetes
screening in the UK appropriately reflects the
differential risks of diabetes. We extend the
analysis to examine whether distinct patterns in
glycaemic control related to ethnicity are suffi-
cient to warrant a reconsideration of disease
management strategies in the UK. The article
adds to current knowledge by extending the
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disaggregation of ethnicity to examine groups
that have not yet been separately studied,
specifically those of Bangladeshi ethnicity. We
also compare socio-economic gradients in
undiagnosed and poorly managed disease across
ethnic groups to shed light on the factors that
might explain their heterogeneous experience
in diagnosis and disease control.
METHODS
Data were extracted from the 2013 Health Sur-
vey for England (HSE). The HSE is an annual
cross-sectional survey of a representative sample
of community-dwelling individuals in England.
Data are collected in two stages. In the first,
respondents complete a health interview that
includes details of self-reported conditions as
well as the respondent’s socio-demographic
characteristics (age, gender, employment status,
income, education, ethnicity, etc.). In the sec-
ond stage the respondent is visited by a nurse
who takes various physical measurements,
records prescribed medication and takes bio-
logical samples. In most years approximately
8000 adults complete the first stage of the sur-
vey and around 6000 the second stage. The
disease focus of the nurse visit varies from year
to year. In 2013 a focus was placed on diabetes.
Further details on the survey are available in
[18]. All analyses reported here are based on this
previously conducted study and do not involve
any new studies of human or animal subjects
performed by any of the authors.
Ethnicity was examined regarding Whites,
Blacks and Asians and, when sample size per-
mitted, within Asians with respect to Bangla-
deshi, Pakistani, Indian and other Asians based
on self-reported status. Undiagnosed diabetes
was a constructed variable based on the
respondent having an HbA1C level over 6.5%
while self-reporting s/he was not diabetic.
Poorly controlled diabetes was a constructed
variable based on the respondent reporting
diabetes as a condition s/he experienced and
having an HbA1C above 6.5%. Other variables
used in the analysis and their precise definition
are presented in Table 4 of ‘‘Appendix 1’’.
The distribution of HbA1C was graphed and
compared visually by ethnic group. Descriptive
statistics (mean and 95% confidence interval)
were estimated and compared by ethnic group
regarding the proportion of respondents who
had undiagnosed and poorly controlled dia-
betes. Erryeger’s (2009) corrected concentration
indices were estimated using the conindex
commands [23] by ethnic group regarding
undiagnosed and poorly controlled disease. The
concentration index measures the distribution
of undiagnosed (and poorly controlled) diabetes
in the sample relative to the distribution of
income. The index is bounded by values of 1
and -1. An over-representation of undiagnosed
diabetes among those with low income would
be reflected in a negative index and an
over-representation among those with high
income by a positive index. Logistic regression
analyses were undertaken in which undiag-
nosed and poorly controlled diabetes respec-
tively were regressed on functions that
controlled for age, BMI, ethnicity, income,
education and smoking status. To allow for the
impact of differential access/use of GP services
in diabetes detection and control, whether the
respondent had visited the GP in the last
12 months was included as a covariate in the
regression analyses. This allowed us to provide a
sharper focus on the success or otherwise of
current primary care screening practices in the
detection and management of diabetes across
ethnic and socio-economic groups. Confirma-
tory analyses were undertaken in which BMI
was included as a series of categorical variables
in the regression analyses with separate thresh-
olds used to define groups at risk based on their
relative risks of complications related to obesity.
Among Chinese, thresholds were based on a
WHO consensus statement [37]; among Indi-
ans, Pakistanis and Bangladeshis they were
based on a consensus statement from a group of
Indian clinicians [19] and for other ethnicities
on existing BMI classifications [37].
RESULTS
Figure 1 displays the distribution of HbA1C by
ethnic groups. As can be seen not only is mean
Diabetes Ther (2017) 8:1163–1174 1165
HbA1C higher among those of Asian ethnicity
relative to Whites but the distributions are also
quite different among specific ethnic Asian
groups. The distribution of Asian’s HbA1C is
typically centred to the right of those for
Whites, for example, while the distribution for
Bangladeshis exhibits a heavier tail than that for
Pakistanis. In Table 1 descriptive statistics reveal
that incomes among Pakistanis and Banglade-
shis is significantly lower than those of Indians
and Whites, the latter also tending to have
higher levels of education.
In Table 2 the concentration indices in
which equivalised household income is used as
a ranking variable and undiagnosed and poorly
controlled diabetes are used as health outcomes
are presented. Small sample sizes precluded the
estimation of indices for each specific ethnic
group regarding undiagnosed disease. As the
table shows, however, distinct patterns between
Whites and Asians exist and regarding poorly
controlled diabetes distinct patterns are evident
among different ethnic groups of South-east
Asians. While a pro-poor gradient is exhibited
regarding poor control for Whites and Indians
for example (that is, more poor Whites and
Indians relative to their representation in the
sample have poorly controlled disease), there is
no significant gradient regarding Pakistanis and
a pro-rich gradient is evident regarding
Bangladeshis.
In Table 3 the results of a series of logistic
regression analyses are presented. Regarding
undiagnosed disease and controlling for having
seen a GP in the past 12 months, those of Asian
ethnicity, those who are older, who are male
and who have a higher BMI are seen to be more
likely to have undiagnosed disease compared to
the relevant comparator groups. Those who
have higher incomes are less likely to be undi-
agnosed compared to those with lower incomes.
Regarding poorly controlled disease and again
controlling for having seen a GP in the past
12 months, those who are Indian, Pakistani and
Bangladeshi are seen to be more likely to have
poorly controlled disease compared to Whites.
While Blacks are also more likely to have poorly
controlled disease this only attains borderline
significance. Those who are better educated and
those with higher incomes are seen to be less
likely to have poorly controlled disease com-
pared to those less well educated and those with
lower incomes. As with undiagnosed, those who
are older and with higher BMI are more likely to
have poorly controlled diabetes. Confirmatory
analysis of undiagnosed and poorly controlled
disease are reported in Table 5 of Appendix 1. As
can be seen Asians remain more likely to expe-
rience undiagnosed disease relative to Whites
adjusting for Chinese and Indian specific BMI
thresholds. For glycaemic control, Pakistanis
and Indians with diabetes remain significantly
less likely to exhibit glycaemic control than
Whites. While Bangladeshis appeared more
likely to exhibit poor glycaemic control this
failed to attain statistical significance.
Fig. 1 Kernel density estimate. kernel = epanechnikov, bandwidth = 0.1362
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DISCUSSION
Previous work has shown that in the UK, Asians
are at greater risk of their diabetes going undi-
agnosed and when diagnosed of it being poorly
controlled [13, 20, 21]. This is reflected to an
extent in current guidance on screening where
NICE [22] suggest that GPs and practice nurses
‘‘…should…consider a blood test for those aged
25 and over of South Asian or Chinese descent
whose body mass index (BMI) is greater than
23 kg/m’’ [22]. Our analyses reveal that despite
this guidance in 2013 Asians remained more
likely to have undiagnosed diabetes than
Whites and among those with diagnosed dia-
betes there is evidence that Indians, Pakistanis
and Bangladeshis in particular were more likely
to exhibit poor glycaemic control. That in both
Table 1 Sample descriptive statistics
Income Median Mean Conﬁdence interval
Whites 24,718.31 33,612.67 32,979.14 34,246.20
Asians 17,769.78 27,664.03 25,249.65 30,078.41
Bangladesh 9919.68 12,023.68 9684.823 14,362.54
Pakistani 13,307.09 20,095.06 15,542.9 24,647.22
Indians 25,514.02 34,608.66 30,471.51 38,745.81
Variable Obs Mean SD Min Max
Having visited GP 8696 0.7832 0.4121 0 1
Age group
25–34 8795 0.1806 0.3847 0 1
35–44 8795 0.1532 0.3602 0 1
45–54 8795 0.2543 0.4355 0 1
Education 8764 0.2708 0.4444 0 1
BMI 8798 25.9056 6.1745 12.4421 63.0914
Smoke
Ex-occasional smoker 8725 0.3221 0.4673 0 1
Never smoker 8725 0.4834 0.4998 0 1
Ethnic
Black 10,946 0.0293 0.1687 0 1
Asian 10,946 0.0732 0.2604 0 1
Mixed 10,946 0.0200 0.1400 0 1
Any other 10,946 0.0092 0.0956 0 1
Male 10,980 0.4577 0.4982 0 1
Tertile of income
Second tertile 8790 0.3226 0.4675 0 1
Highest tertile 8790 0.3373 0.4728 0 1
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instances elevated risks existed in regressions
where contact with doctor services was con-
trolled for indicates that this is not simply an
issue of potentially lower service uptake by
these groups but also of the manner in which
these groups are served.
Regarding undiagnosed disease, as seen in
Table 3, the magnitude of the penalty experi-
enced by Asians is significant and independent
of age and BMI. (These results are supported by
confirmatory analysis reported in Table 5 ‘‘Ap-
pendix 1’’.) The marginal effect of Asian eth-
nicity on risk of undiagnosed disease is
equivalent to approximately 14 BMI points.
That is, it is equivalent to moving someone
from underweight to obese. Given the effects of
ethnicity are independent of age and BMI, it is
debatable whether the ethnicity risk premium is
appropriately reflected in current guidance,
which refers to consideration being given to
testing conditional on age and BMI. In short, it
could be argued that advice might usefully be
rephrased as ‘‘GPs and practice nurses should
offer a blood test to persons of South Asian or
Chinese descent regardless of age and BMI sta-
tus’’. While such a change would require an
assessment of its cost effectiveness and bud-
getary impact, it seems reasonable that it should
at a minimum be investigated.
Regarding the management of diabetes, as
seen in Table 3, currently those of Indian, Pak-
istani and Bangladeshi descent exhibit poorer
glycaemic control relative to Whites controlling
for age, BMI and socio-economic status. (These
results are largely supported by confirmatory
analyses in Table 5 of the ‘‘Appendix 1’’. While
the result regarding Bangladeshis failed to attain
statistical significance this may indicate a
poorer correlation in risk between
Indian-specific BMI thresholds and disease risk
among Bangladeshis.) Again the extent of ele-
vated risk can be assessed by comparison with
the change in BMI that would be required to
raise risk by an equivalent amount. In Table 3
with respect to diabetic Pakistanis, the marginal
effect of their ethnicity on having an HbA1C
measure that exceeds 6.5% is equivalent to a
change in BMI of approximately 46 BMI points
(moving from underweight to extreme obesity).
Given this, it is questionable whether cur-
rent incentives contained within the UK’s
Quality Outcomes Framework are sufficient or
are sufficiently targeted to address poor gly-
caemic control among several Asian groups.
As with the failure to detect diabetes, failure
to control blood sugar among diabetics will
impact directly on the economic burden of the
disease and on the distribution of that burden.
In the UK, the estimated cost of diabetes in
2010/11 was £23.7 billion of which £9 billion
was estimated to be born directly by patients
and their families in the form of higher absen-
teeism, presenteeism, informal care and mor-
tality [11]. It seems reasonable to conclude that
Table 2 Concentration indices regarding diabetes control and diagnosis by ethnic group
Poorly controlled group Concentration index Conﬁdence interval N
Poorly controlled (Bangladesh) 0.09375 0.0406 0.1470 32
Poorly controlled (Pakistani) -0.1600 -0.3455 0.0255 10
Poorly controlled (Indians) -0.0400 -0.0615 -0.0215 68
Poorly controlled (Asians) -0.01951 -0.0273 -0.0117 167
Poorly controlled (Whites) -0.0528 -0.5283 -0.0525 3447
Undiagnosed (all) -0.0543 -0.0547 -0.0540 3747
Undiagnosed (White) -0.0429 -0.0433 -0.0426 3447
Undiagnosed (Black) -0.0048 -0.0099 0.0195 65
Undiagnosed (Asian) -0.0719 -0.0780 -0.0658 167
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a substantial proportion of this burden might be
avoided if the disease is detected earlier and
effective management adopted before compli-
cations associated with it can accumulate
[8, 10, 34]. This has the potential to reduce both
the burden of disease and disparities in the
distribution of that burden. As with diagnosis,
using ethnicity to help target disease manage-
ment efforts would have to be assessed in terms
of its cost effectiveness and budgetary impact.
As with diagnosis, however, that such a policy
should be investigated seems reasonable.
Table 3 Logistic regression analyses
Variables Undiagnosed diabetes
margins
Poorly controlled diabetes
margins
visit_GP 0.0114 (0.00789) 0.0273** (0.0107)
Age group (ref.: 16–44)
45–54 0.0132** (0.00621) 0.0215*** (0.00762)
55–64 0.0327*** (0.00872) 0.0379*** (0.00922)
65? 0.0416*** (0.00878) 0.0709*** (0.00977)
Education (age person ﬁnished continuous full-time
education C19)
-3.72e-05 (0.00751) -0.0217** (0.00986)
BMI 0.00327*** (0.000546) 0.00461*** (0.000620)
Ex-occasional/regular smoker -0.0147 (0.00988) 0.00557 (0.0103)
Current smoker -0.0143 (0.00981) -0.00210 (0.0100)
Ethnicity (ref.: whites)
Black 0.0777* (0.0434)
Indian 0.142*** (0.0522)
Pakistani 0.212*** (0.0735)
Bangladeshi 0.284** (0.129)
Chinese and other Asian 0.0194 (0.0453)
Chinese
Other asian
Mixed -0.00998 (0.0255)
Any other 0.0451 (0.0715)
Male 0.0154*** (0.00580) 0.0210*** (0.00698)
17,402–34,788 0.00254 (0.00752) -0.00294 (0.00860)
[34,788 -0.0162** (0.00686) -0.0178** (0.00866)
Black 0.0188 (0.0199)
Asian 0.0467*** (0.0121)
Observations 3205 3408
Note: margins report average partial effects. Figures in parentheses report standard errors
*** Signiﬁcant at p\0.01; ** signiﬁcance at p\0.05; * signiﬁcance at p\0.1
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Consideration of our results regarding con-
centration indices alongside regression analyses
provides potentially valuable insights into the
source of difference between ethnic groups.
Both Asians and Whites exhibit a pro-poor
pattern of undiagnosed disease, that is, one in
which those who are less well off are over-rep-
resented among undetected diabetics relative to
their representation in the population. This
indicates a role for poverty in the failure to
detect diabetes, an inference supported by the
statistical significance of income in the regres-
sion analysis. The picture may be somewhat
more complex than this though. Thus while the
concentration index among Asians is signifi-
cantly higher in absolute terms than that for
Whites—suggesting poverty among Asians may
have a particularly deleterious effect—the
heterogeneous experience of Asians regarding
glycaemic control may well be mirrored in
respect to undiagnosed disease. Sample size
meant it was not possible for us to pursue this
line of enquiry but it is one that warrants fur-
ther research.
As noted by Rhodes et al. [27], with specific
reference to Bangladeshi diabetics, language,
culture and poverty may combine to present
particular barriers in terms of both access to care
and the quality of care received when accessed.
The ability to afford transport, prolonged visits
to Bangladesh during which access to ongoing
care may not be possible as well as cultural
issues around women attending clinics were
cited as issues in access and quality of care. Such
issues may present differential barriers to those
who are relatively more recent migrants to
England than those who have a more estab-
lished history in the country. It is notable, for
example, that among South-east Asians, in
terms of waves of migrants Indians preceded
Pakistanis who in turn preceded Bangladeshis to
the UK [24]. This sequence mirrors the rank
order of marginal effects in diabetes control
suggesting not just language but assimilation
more generally may contribute to differences
between ethnicities in observed glycaemic con-
trol. Unfortunately, it was not possible to
explore the relationship among migration his-
tory, diagnosis and glycaemic control with the
data available in the Health Survey for England
as information on how recently families
migrated was not recorded. This area though
does offer a potentially fruitful line of future
investigation.
Beyond ethnicity the negative association
among disease control, income and education
after controlling for use of GP services are con-
sistent with the predictions of the Grossman
health investment model [6]. This model pre-
dicts that as income increases and/or as educa-
tion increases so too will investments in health.
The relative magnitude of the two marginal
effects in this case is instructive. Finishing
education after 19 years of full-time education
compared to earlier was more than equivalent
to a move from the lowest to the highest
income tertile (a change that would involve
approximately £17,386 per annum in this
sample). This suggests that in terms of its
impact on health, education has a larger effect
than income. These findings regarding the rel-
ative magnitude of education and income are
consistent with those of other authors who
show education to have a higher impact on
health [3, 35] and health-improving behaviours
[3]. They also underscore the limitations of
healthcare as a means of addressing broader
socio-economic disparities though. Whether
more forceful screening strategies, health pro-
motion and aggressive disease management
framed around personalised medicine can
address some of the disparities noted in this
study warrants further investigation.
CONCLUSIONS
This article has demonstrated that after con-
trolling for use of GP services Asians are at
higher risk of undetected diabetes than are
Whites in England. It has shown that among
Asians distinct patterns in glycaemic control are
evident with those of Pakistani and Indian
descent experiencing particular disadvantage
and evidence indicating this may also extend to
Bangladeshis. Our analysis suggests that current
guidance on screening for diabetes may not
adequately reflect the relative risks experienced
by ethnic minorities and barriers may exist that
limit the effectiveness of current practice
1170 Diabetes Ther (2017) 8:1163–1174
regarding glycaemic control. Our findings on
socio-economic status, however, also under-
score the limitations of healthcare to address
inequalities whose origins reflect broader
inequalities in society related to education and
incomes.
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APPENDIX 1
See Tables 4 and 5.
Table 4 Deﬁnition of variables used in regression analyses
Variable Deﬁnition
Visited GP Having visited GP in the past
12 months
Age group 16–24
25–34
35–44
45–54
Education Age person ﬁnished continuous
full-time education. =1 if C19
BMI Body mass index
Smoking status Never smoker
Ex-occasional smoker
Never smoker
Ethnic Black
Asian
Mixed
Any other
Gender Male = 1
Tertile of income Lowest tertile (B17,402)
Second tertile (17,402–34,788)
Highest tertile ([34,788)
BMI categories
Others1
Underweight Below 18.5
Normal weight 18.5–24.9
At risk
(overweight)
25–29.9
At higher risk
(obese)
30?
Chinese1
Underweight Below 18.5
Normal weight 18.5–22.9
At risk
(overweight)
23–27.49
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Table 4 continued
Variable Deﬁnition
At higher risk
(obese)
27.5?
Indian, Pakistani, Bangladeshi2
Underweight \18
Normal weight 18–22.9
At risk
(overweight)
23–24.9
At higher risk
(obese)
25?
1 [37]
2 [19]
Table 5 Logistic regression analyses
Variables Undiagnosed
margins
Poor margins
Visit_GP 0.0174**
(0.00800)
0.0353***
(0.0112)
Age group (ref.: 16–44)
45–54 0.0132**
(0.00579)
0.0266***
(0.00775)
55–64 0.0359***
(0.00898)
0.0426***
(0.00945)
65? 0.0409***
(0.00848)
0.0752***
(0.00935)
edu -0.00628
(0.00743)
-0.0254**
(0.0101)
Obesity status (ref.: underweight/normal weight)
Over 0.00300
(0.00511)
0.00638
(0.00650)
Obese 0.0396***
(0.00742)
0.0654***
(0.00876)
Smoking status (ref.: non-smoker)
Ex-occasional/
regular smoker
-0.00944
(0.00909)
0.00687
(0.0102)
Current smoker -0.00836
(0.00886)
-0.000764
(0.00989)
Table 5 continued
Variables Undiagnosed
margins
Poor margins
Ethnicity (ref.: Whites)
Black 0.0798*
(0.0450)
Indian 0.0789**
(0.0395)
Pakistani 0.150**
(0.0639)
Bangladeshi 0.118 (0.0878)
Chinese and other
Asian
-0.00110
(0.0351)
Mixed -0.00943
(0.0333)
Any other 0.0652
(0.0663)
Male 0.0163***
(0.00569)
0.0175**
(0.00700)
Tertile of income (ref.:\17,402)
17,402–34,788 0.00156
(0.00744)
-0.00576
(0.00856)
[34,788 -0.0153**
(0.00670)
-0.0218**
(0.00861)
Black 0.0313*
(0.0171)
Asian 0.0351***
(0.0124)
Observations 3397 3651
Standard errors in parentheses
*** p\0.01; ** p\0.05; * p\0.1
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